INTRODUCTION
Study of biotransformation of various materials by using biocatalysts is important for elucidating the metabolic pathways in the human body 1 3 . Terpenoids are known not only as raw materials for flavor and fragrance, but also as biologically active substances 4, 5 . In our previous studies, we examined the in vitro metabolism of monoterpenoids by using human liver microsomes and recombinant enzymes 6 10 . Although terpenoids are essential for life, their metabolism in the human body has not been clarified.
-Fenchone compound 1 , a bicyclic monoterpene, is widely distributed in plants and found in oil extracts from Foeniculum vulgare and Lavandula luisieri 11, 12 and has a camphoraceous fragrance 13 . Compound 1 is used as a food flavor and in perfumes, even though compound 1 has been reported to be toxic 14 . P450 enzymes have been shown to detoxify and/or toxify cells by converting these compounds to more polar and sometimes to more reactive metabolites 15 17 .
We have reported that larvae of the common cutworm Spodoptera litura convert compound 1 to -1S,6R -6-endo-hydroxyfenchone compound 2 , -1S,6S -6-exo-hydroxyfenchone compound 3 , -1R -10-hydroxyfenchone, and -1S,5S -5-exo-hydroxyfenchone, and that rabbits convert compound 1 to 8-hydroxyfenchone 18, 19 . Other studies have indicated that cultured cells of Eucalyptus perriniana convert compound 1 to several glycosidic metabolites 20 . In particular, compound 1 was oxidized to compound 2 and compound 3 by the human liver microsomal cytochrome P450 enzymes cytochrome P450 CYP2A6 and NADPH-P450 reductase 7 . However, because production of large concentrations of metabolites by using this experimental system was difficult, the metabolites were only identified using gas chromatography GC and a combination of gas chromatography-mass spectrometry GC-MS . We therefore, performed similar reactions using Salmonella typhimurium OY1002/2A6 and successfully obtained large amounts of metabolites 21 .
In this study, the biotransformation of compound 1 by S. typhimurium OY1002/2A6 expressing human CYP2A6 and NADPH-P450 reductase as a biocatalyst was investigated for the capacity of this microorganism to produce large concentrations of reaction metabolites and to further elucidate the metabolic pathway in humans.
NOTE
Abstract: In this study, biotransformation of (+)-fenchone (compound 1) by Salmonella typhimurium OY1002/2A6 expressing human CYP2A6 and NADPH-P450 reductase yielded two oxidized metabolites, namely, (+)-(1S,6R)-6-endo-hydroxyfenchone (compound 2) and (+)-(1S,6S)-6-exo-hydroxyfenchone (compound 3). The conversion rate of compound 1 to compound 2 and 3 was 2.4% and 5.2%, respectively. This is the first study that succeeded in metabolizing compound 1 to obtain large amounts of metabolite 2 and 3 by using S. typhimurium OY1002/2A6 expressing human CYP2A6 and NADPH-P450 reductase.
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MATERIALS AND METHODS
Materials
-Fenchone 1 was purchased from Fluka Tokyo, Japan . Isopropyl β-D-thiogalactoside was purchased from Wako Pure Chemical Osaka, Japan , and δ-aminolevulinic acid δ-ALA was from Sigma Chemical Co. St. Louis, MO, USA .
Strains
S. typhimurium OY1002/2A6 was constructed by introducing plasmid pCW /2A6: hNPR carrying cDNA of CYP2A6 and NADPH-P450 reductase , which is an isopropyl β-D-thiogalactopyranoside IPTG -inducible bicistronic construct, and S. typhimurium TA1535 was constructed by introducing the plasmid pOA101 carrying the umuC lacz fusion gene 22 24 .
Preculture of S. typhimurium OY1002/2A6
A single colony of S. typhimurium OY1002/2A6 was grown overnight in LB medium containing ampicillin 50 mg/L at 37 with shaking 160 rpm .
Time course in the biotransformation of
-fenchone by S. typhimurium OY1002/2A6 Precultured S. typhimurium OY1002/2A6 was transferred into a 300-mL Erlenmeyer flask containing 100 mL of LB medium supplemented with ampicillin 50 mg/L . The culture conditions were the same as above until the culture reached an optical density of 0.6-0.8 at 600 nm. Thereafter, 0.2 M potassium phosphate buffer 10 mL, pH7.0 , 1 M IPTG 100 μL , trace elements 25 μL , 10 glycerol 400 μL , 1 M δ-ALA 50 μL , and compound 1 20 mg, 0.13 mmol in 1.0 mL of dimethyl sulfoxide DMSO were added to the Erlenmeyer flask. The culture was stirred at 37 for 24 h; thereafter, the medium was salted out with NaCl and extracted with diethyl ether. The extract was analyzed by GC. The ratio of the amount of substrate 1 and to that of metabolic products was determined on basis of the peak areas of GC and GC-MS.
Isolation of metabolites
Precultured S. typhimurium OY1002/2A6 was transferred into a 300-mL Erlenmeyer flask containing 100 mL of LB medium supplemented with ampicillin 50 mg/L and stirred at 37 until the optical density of the culture reached 0.6-0.8 at 600 nm. Thereafter, 0.2 M potassium phosphate buffer 10 mL, pH7.0 , 1 M IPTG 100 μL , trace elements 25 μL , 10 glycerol 400 μL , 1 M δ-ALA 50 μL , and compound 1 20 mg, 0.13 mmol in 1.0 mL of dimethyl sulfoxide DMSO were added to the Erlenmeyer flask. The medium was stirred at 37 for 24 h. In order to isolate the metabolites, several similar small-scale cultures were carried out. Subsequently, the medium was salted out with NaCl and extracted with diethyl ether. The diethyl ether extracts were mixed and dried over Na 2 SO 4 , and the solvent was evaporated to yield the crude extract 1264 mg . The extract was separated by chromatography using silica-200 columns with diethyl ether-hexane as explained below . Metabolite 2 4.8 mg, 2.4 and 3 10.4 mg, 5.2 were isolated.
Chromatography
For column chromatography CC , silica gel developed with a hexane-EtOAc gradient was used. For GC, a 5890N gas chromatograph Agilent Technologies Inc. equipped with a flame ionization detector, a HP-5 capillary column 30 m length, 0.25 mm inner diameter , and a split injection of 20:1 was used. Helium was used as a carrier gas at a flow rate of 1 mL/min. The oven temperature was programmed from 40 to 270 at a rate of 4 /min. The injector and detector temperatures were 270 and 280 , respectively. System software control and data analyses were performed with GC Chemstation software Agilent Technologies Inc. .
For GC-MS analysis, a 5890A gas chromatograph Hewlett-Packard equipped with a split injector HP-5MS capillary column 30 m length, 0.25 mm inner diameter , was combined by direct coupling to a 5972N mass spectrometer Hewlett-Packard . The same temperature program described above was used. Helium at 1 mL/min was used as a carrier gas. The electron energy was 70 eV, and the ion source temperature was 280 . Nuclear magnetic resonance NMR was performed at 400 MHz 1 H and 100 MHz 13 C , in CDCl 3 with tetramethylsilane TMS as the internal standard.
RESULTS AND DISCUSSION
Biotransformation of compound 1 by S. typhimurium OY1002/2A6
The biotransformation of compound 1 by S. typhimurium OY1002/2A6 was investigated. For time-course experiments, a small amount of compound 1 was incubated with S. typhimurium OY1002/2A6 for 24 h. Compound 1 was transformed into two metabolites, which were confirmed by GC and GC-MS analyses, and the amount of compound 1 was found to decrease gradually Fig. 1 . Metabolite 2 and 3 were not formed without IPTG, suggesting that compound 1 was transformed to metabolite 2 and 3 by S. typhimurium OY1002/2A6 only when human cytochrome P450 2A6 and human NADPH-P450 reductase were expressed. Fig. 2 shows the time course for the appearance of the metabolites.
To isolate the metabolites, several repetitions of the small-scale experiments were carried out, and the culture was extracted as described under Materials and Methods. These metabolites were isolated from the diethyl ether extract, and the structures were determined to correspond to -1S,6R -6-endo-hydroxyfenchone compound 2 and -1S,6S -6-exo-hydroxyfenchone compound 3 by 1 H NMR, 13 C NMR, and mass spectra with a comparison to reported data 7, 18 Fig. 3 .
In previous studies, the metabolites synthesized by human liver microsomes and human CYP2A6 had been identified by GC and GC-MS; however, the amount of metabolites produced was insufficient to be confirmed through 1 H NMR and 13 C NMR 6 10 . In this study, we succeeded in obtaining large quantities of compound 2 and 3 by using S. typhimurium OY1002/2A6. The structures of compound 2 and 3 were determined in detail by 1 H NMR and 13 C NMR.
In this experimental system using S. typhimurium OY1002/2A6 expressing human CYP2A6 and human NADPH-P450 reductase, 200 mg of compound 1 was converted to 4.8 mg of compound 2 and 10.4 mg of compound 3. In previous kinetic analysis, the V max /K m values for -fenchone 6-endo and 6-exo catalyzed by CYP2A6 were 150.2 and 166.8 nmol/ min nmol P450 respectively 7 . In this study, compound 3 was preferentially produced by a mechanism similar to human microsomal metabolism. There have been reports that fenchone shows strong species-specific toxicity 25 . However, detailed investigations about hydroxyfenchone toxicity have not been reported. Finally, we investigated the biotransformation of bicyclic monoterpenes consisting of a carbonyl group, such as -verbenone, -fenchone, and -camphor, by CYP2A6 6 10 .
The opposite side of the carbonyl group was oxidized by CYP2A6 in all substrates. The data suggest that the carbonyl group plays an important role. Many pharmaceutical medicines and agrochemicals are metabolized by CYPs. In particular, CYP2B6 metabolizes a large number of agrochemicals, and is the most essential P450 isoform in agrochemical metabolism 26, 27 . Reproduction of the biokinetics of agrochemical metabolism by using S. typhimurium OY1002/2B6 and the methods described in this study may assist in elucidation of the biological mechanisms of human metabolism.
In conclusion, the experimental system consisting of S. typhimurium OY1002/2A6 expressing human CYP2A6 and NADPH-P450 reductase produced more than several milligrams of metabolite 2 and 3, while previous experimental systems produced only microgram amounts of the two metabolites 6 10 . 
